Değer202020212022202320242025TTMSatış/genel/idari giderler5.36 B6.43 B6.46 B7.13 B7.68 B8.65 B8.63 BAraştırma ve geliştirme984 M1.24 B1.45 B1.39 B1.47 B1.62 B1.63 BFaaliyet karı2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.99 BFaaliyet Dışı Gelir, Toplam-269 M-303 M-158 M-215 M-197 M232 M230 MFaiz gideri (aktifleştirilmiş faizler düşüldükten sonra)315 M337 M337 M356 M396 M607 M593 MFaaliyet Dışı Gelir (Faiz Giderleri Hariç)-269 M-303 M-158 M-215 M-197 M-375 M-363 MOlağandışı gelirler/giderler———————Vergi öncesi kar1.95 B2.28 B2.68 B3.67 B3.49 B4.51 B4.6 BKazançlardaki özsermayeler———————Vergiler355 M287 M325 M508 M499 M1.27 B1.26 BKontrol gücü olmayan/azınlık payı———————Vergi sonrası diğer gelirler/giderler———————Durdurulan faaliyetler öncesi net kar1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BDurdurulan faaliyetler———————Net kar1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BSeyreltme ayarlaması———————İmtiyazlı temettüler———————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BTemel hisse başına kazanç (Temel EPS)4.265.296.238.347.868.498.73Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)4.25.216.178.257.768.48.64Dolaşımdaki ortalama adi hisse senedi sayısı375.5 M377 M378.2 M379.6 M381 M382.2 M—Dolaşımdaki seyreltilmiş hisse senedi sayısı380.3 M382.3 M382.2 M383.7 M385.6 M386.5 M—FAVÖK3.3 B3.86 B4.12 B5.23 B5.12 B6.46 B6.59 BFVÖK2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.99 BGelir maliyeti5.29 B6.14 B6.87 B7.44 B8.15 B9.05 B9.14 BSatılan malların diğer maliyeti———————Amortisman ve itfa (nakit akışı)1.08 B1.27 B1.28 B1.34 B1.43 B1.57 B1.61 B
Stryker Corporation Common Stock
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.